No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9591177 |
chr13:49134412-49134413 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs556348045 |
chr13:49134465-49134466 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs147025872 |
chr13:49134474-49134475 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs548519180 |
chr13:49134574-49134575 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs561617669 |
chr13:49134576-49134577 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs73489012 |
chr13:49134604-49134605 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs557561274 |
chr13:49134607-49134608 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs530715461 |
chr13:49134623-49134624 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs138398385 |
chr13:49134644-49134645 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs386770812 |
chr13:49134649-49134650 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs9591178 |
chr13:49134650-49134651 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs199634530 |
chr13:49134764-49134765 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs574726626 |
chr13:49134799-49134800 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs541866965 |
chr13:49134866-49134867 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs564118532 |
chr13:49134882-49134883 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563973208 |
chr13:49134886-49134887 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs575869128 |
chr13:49134946-49134947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs76194270 |
chr13:49134957-49134958 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs564711602 |
chr13:49134965-49134966 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs111706626 |
chr13:49134997-49134998 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs187872203 |
chr13:49135019-49135020 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs546358724 |
chr13:49135042-49135043 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs143913111 |
chr13:49135043-49135044 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs566596688 |
chr13:49135088-49135089 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs192748095 |
chr13:49135156-49135157 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs550330548 |
chr13:49135158-49135159 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs569113428 |
chr13:49135208-49135209 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs146856553 |
chr13:49135211-49135212 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs56179737 |
chr13:49135221-49135222 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs189429737 |
chr13:49135247-49135248 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs533737667 |
chr13:49135256-49135257 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs60646582 |
chr13:49135261-49135262 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs115533505 |
chr13:49135265-49135266 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs569526226 |
chr13:49135276-49135277 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs74768400 |
chr13:49135289-49135290 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs557104205 |
chr13:49135294-49135295 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs575878049 |
chr13:49135327-49135328 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs74074955 |
chr13:49135395-49135396 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs558493880 |
chr13:49135404-49135405 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs558533666 |
chr13:49135468-49135469 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs149439161 |
chr13:49135483-49135484 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs540846701 |
chr13:49135498-49135499 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs73489016 |
chr13:49135529-49135530 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs35990381 |
chr13:49135551-49135552 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs529009117 |
chr13:49135556-49135557 |
Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs373659557 |
chr13:49135640-49135641 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs192477655 |
chr13:49135662-49135663 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs562387964 |
chr13:49135675-49135676 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs533249962 |
chr13:49135676-49135677 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs551211673 |
chr13:49135686-49135687 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|